Cardiocomm Solutions Stock Performance
| EKGGF Stock | USD 0.01 0.00 0.00% |
CardioComm Solutions holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CardioComm Solutions are expected to decrease at a much lower rate. During the bear market, CardioComm Solutions is likely to outperform the market. Use CardioComm Solutions information ratio, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on CardioComm Solutions.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CardioComm Solutions are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, CardioComm Solutions reported solid returns over the last few months and may actually be approaching a breakup point. ...more
CardioComm |
CardioComm Solutions Relative Risk vs. Return Landscape
If you would invest 0.40 in CardioComm Solutions on September 23, 2025 and sell it today you would earn a total of 0.33 from holding CardioComm Solutions or generate 82.5% return on investment over 90 days. CardioComm Solutions is currently producing 1.9198% returns and takes up 18.6264% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than CardioComm, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CardioComm Solutions Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CardioComm Solutions' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CardioComm Solutions, and traders can use it to determine the average amount a CardioComm Solutions' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1031
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | EKGGF | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average CardioComm Solutions is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CardioComm Solutions by adding it to a well-diversified portfolio.
CardioComm Solutions Fundamentals Growth
CardioComm Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CardioComm Solutions, and CardioComm Solutions fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CardioComm Pink Sheet performance.
| Return On Asset | 0.16 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 151.16 M | |||
| Price To Sales | 1.62 X | |||
| Revenue | 682.51 K | |||
| EBITDA | 61.24 K | |||
| Cash And Equivalents | 153.45 K | |||
| Total Debt | 413.81 K | |||
| Debt To Equity | 430.30 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (120.8 K) | |||
| Total Asset | 486.47 K | |||
About CardioComm Solutions Performance
By analyzing CardioComm Solutions' fundamental ratios, stakeholders can gain valuable insights into CardioComm Solutions' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CardioComm Solutions has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CardioComm Solutions has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange.Things to note about CardioComm Solutions performance evaluation
Checking the ongoing alerts about CardioComm Solutions for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CardioComm Solutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CardioComm Solutions is way too risky over 90 days horizon | |
| CardioComm Solutions has some characteristics of a very speculative penny stock | |
| CardioComm Solutions appears to be risky and price may revert if volatility continues | |
| CardioComm Solutions has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| CardioComm Solutions has accumulated 413.81 K in total debt with debt to equity ratio (D/E) of 430.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CardioComm Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, CardioComm Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardioComm Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardioComm to invest in growth at high rates of return. When we think about CardioComm Solutions' use of debt, we should always consider it together with cash and equity. | |
| CardioComm Solutions has accumulated about 153.45 K in cash with (120.8 K) of positive cash flow from operations. | |
| Roughly 38.0% of CardioComm Solutions shares are held by company insiders | |
| Latest headline from cnbc.com: Acquisition by Brian Hannasch of 147 shares of AutoZone at 3393.09 subject to Rule 16b-3 |
- Analyzing CardioComm Solutions' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CardioComm Solutions' stock is overvalued or undervalued compared to its peers.
- Examining CardioComm Solutions' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CardioComm Solutions' management team can have a significant impact on its success or failure. Reviewing the track record and experience of CardioComm Solutions' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CardioComm Solutions' pink sheet. These opinions can provide insight into CardioComm Solutions' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CardioComm Pink Sheet analysis
When running CardioComm Solutions' price analysis, check to measure CardioComm Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioComm Solutions is operating at the current time. Most of CardioComm Solutions' value examination focuses on studying past and present price action to predict the probability of CardioComm Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioComm Solutions' price. Additionally, you may evaluate how the addition of CardioComm Solutions to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |